A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

Clinical trial NCT07392372 · RECRUITING

Trial details

NCT number: NCT07392372
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HIV -1 Infection

Start date: 2026-02-09
Primary completion: 2026-11-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.